HF
BCYC

HRT Financial’s Bicycle Therapeutics BCYC Stock Holding History

HRT Financial’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Buy
+45,915
New +$262K ﹤0.01% 3158
2024
Q1 		– Sell
-19,913
Closed -$360K – 2332
2023
Q4 		$360K Buy
+19,913
New +$329K ﹤0.01% 1539

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's BCYC Position: Q1 2026 in Review

HRT Financial opened a new position in Bicycle Therapeutics (BCYC) in Q1 2026: 45,915 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #3158 among its holdings. This is a return to the name: HRT Financial previously reported a position in BCYC as recently as Q4 2023.

HRT Financial first reported a position in BCYC in Q4 2023 and has held it in 2 quarters since. The position peaked at $360K in Q4 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • HRT Financial held 45,915 shares of Bicycle Therapeutics worth $213K as of Q1 2026.
  • Bicycle Therapeutics was a new HRT Financial position in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3158 holding.
  • HRT Financial first reported a position in Bicycle Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • HRT Financial's Bicycle Therapeutics position peaked at $360K in Q4 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.